Recently, ML323 effectively suppressed the proliferation of HCC and ESCC cells, inhibited TGF‐β induced EMT in TNBC cells, and induced apoptosis and DNA damage in ESCC cells, demonstrating its potential as a viable anticancer treatment.430. This evidence concerns the gene TGFB1 and esophageal squamous cell carcinoma.